Cargando…

Prevalence and Therapy Rates for Stuttering, Cluttering, and Developmental Disorders of Speech and Language: Evaluation of German Health Insurance Data

PURPOSE: To evaluate the prevalence and treatment patterns of speech and language disorders in Germany. METHODS: A retrospective analysis of data collected from 32% of the German population, insured by the statutory German health insurance (AOK, Local Health Care Funds). We used The International St...

Descripción completa

Detalles Bibliográficos
Autores principales: Sommer, Martin, Waltersbacher, Andrea, Schlotmann, Andreas, Schröder, Helmut, Strzelczyk, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071871/
https://www.ncbi.nlm.nih.gov/pubmed/33912020
http://dx.doi.org/10.3389/fnhum.2021.645292
_version_ 1783683799694966784
author Sommer, Martin
Waltersbacher, Andrea
Schlotmann, Andreas
Schröder, Helmut
Strzelczyk, Adam
author_facet Sommer, Martin
Waltersbacher, Andrea
Schlotmann, Andreas
Schröder, Helmut
Strzelczyk, Adam
author_sort Sommer, Martin
collection PubMed
description PURPOSE: To evaluate the prevalence and treatment patterns of speech and language disorders in Germany. METHODS: A retrospective analysis of data collected from 32% of the German population, insured by the statutory German health insurance (AOK, Local Health Care Funds). We used The International Statistical Classification of Diseases and Related Health Problems, 10th revision, German Modification (ICD-10 GM) codes for stuttering (F98.5), cluttering (F98.6), and developmental disorders of speech and language (F80) to identify prevalent and newly diagnosed cases each year. Prescription and speech therapy reimbursement data were used to evaluate treatment patterns. RESULTS: In 2017, 27,977 patients of all ages were diagnosed with stuttering (21,045 males, 75% and 6,932 females, 25%). Stuttering prevalence peaks at age 5 years (boys, 0.89% and girls, 0.40%). Cluttering was diagnosed in 1,800 patients of all ages (1,287 males, 71.5% and 513 females, 28.5%). Developmental disorders of speech and language were identified in 555,774 AOK-insurants (61.2% males and 38.8% females). Treatment data indicate a substantial proportion newly diagnosed stuttering individuals receive treatment (up to 45% of 6-year-old patients), with slightly fewer than 20 sessions per year, on average. We confirmed a previous study showing increased rates of atopic disorders and neurological and psychiatric comorbidities in individuals with stuttering, cluttering, and developmental disorders of speech and language. CONCLUSION: This is the first nationwide study using health insurance data to analyze the prevalence and newly diagnosed cases of a speech and language disorder. Prevalence and gender ratio data were consistent with the international literature. The crude prevalence of developmental disorders of speech and language increased from 2015 to 2018, whereas the crude prevalence for stuttering remained stable. For cluttering, the numbers were too low to draw reliable conclusions. Proportional treatment allocation for stuttering peaked at 6 years of age, which is the school entrance year, and is later than the prevalence peak of stuttering.
format Online
Article
Text
id pubmed-8071871
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80718712021-04-27 Prevalence and Therapy Rates for Stuttering, Cluttering, and Developmental Disorders of Speech and Language: Evaluation of German Health Insurance Data Sommer, Martin Waltersbacher, Andrea Schlotmann, Andreas Schröder, Helmut Strzelczyk, Adam Front Hum Neurosci Neuroscience PURPOSE: To evaluate the prevalence and treatment patterns of speech and language disorders in Germany. METHODS: A retrospective analysis of data collected from 32% of the German population, insured by the statutory German health insurance (AOK, Local Health Care Funds). We used The International Statistical Classification of Diseases and Related Health Problems, 10th revision, German Modification (ICD-10 GM) codes for stuttering (F98.5), cluttering (F98.6), and developmental disorders of speech and language (F80) to identify prevalent and newly diagnosed cases each year. Prescription and speech therapy reimbursement data were used to evaluate treatment patterns. RESULTS: In 2017, 27,977 patients of all ages were diagnosed with stuttering (21,045 males, 75% and 6,932 females, 25%). Stuttering prevalence peaks at age 5 years (boys, 0.89% and girls, 0.40%). Cluttering was diagnosed in 1,800 patients of all ages (1,287 males, 71.5% and 513 females, 28.5%). Developmental disorders of speech and language were identified in 555,774 AOK-insurants (61.2% males and 38.8% females). Treatment data indicate a substantial proportion newly diagnosed stuttering individuals receive treatment (up to 45% of 6-year-old patients), with slightly fewer than 20 sessions per year, on average. We confirmed a previous study showing increased rates of atopic disorders and neurological and psychiatric comorbidities in individuals with stuttering, cluttering, and developmental disorders of speech and language. CONCLUSION: This is the first nationwide study using health insurance data to analyze the prevalence and newly diagnosed cases of a speech and language disorder. Prevalence and gender ratio data were consistent with the international literature. The crude prevalence of developmental disorders of speech and language increased from 2015 to 2018, whereas the crude prevalence for stuttering remained stable. For cluttering, the numbers were too low to draw reliable conclusions. Proportional treatment allocation for stuttering peaked at 6 years of age, which is the school entrance year, and is later than the prevalence peak of stuttering. Frontiers Media S.A. 2021-04-12 /pmc/articles/PMC8071871/ /pubmed/33912020 http://dx.doi.org/10.3389/fnhum.2021.645292 Text en Copyright © 2021 Sommer, Waltersbacher, Schlotmann, Schröder and Strzelczyk. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Sommer, Martin
Waltersbacher, Andrea
Schlotmann, Andreas
Schröder, Helmut
Strzelczyk, Adam
Prevalence and Therapy Rates for Stuttering, Cluttering, and Developmental Disorders of Speech and Language: Evaluation of German Health Insurance Data
title Prevalence and Therapy Rates for Stuttering, Cluttering, and Developmental Disorders of Speech and Language: Evaluation of German Health Insurance Data
title_full Prevalence and Therapy Rates for Stuttering, Cluttering, and Developmental Disorders of Speech and Language: Evaluation of German Health Insurance Data
title_fullStr Prevalence and Therapy Rates for Stuttering, Cluttering, and Developmental Disorders of Speech and Language: Evaluation of German Health Insurance Data
title_full_unstemmed Prevalence and Therapy Rates for Stuttering, Cluttering, and Developmental Disorders of Speech and Language: Evaluation of German Health Insurance Data
title_short Prevalence and Therapy Rates for Stuttering, Cluttering, and Developmental Disorders of Speech and Language: Evaluation of German Health Insurance Data
title_sort prevalence and therapy rates for stuttering, cluttering, and developmental disorders of speech and language: evaluation of german health insurance data
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071871/
https://www.ncbi.nlm.nih.gov/pubmed/33912020
http://dx.doi.org/10.3389/fnhum.2021.645292
work_keys_str_mv AT sommermartin prevalenceandtherapyratesforstutteringclutteringanddevelopmentaldisordersofspeechandlanguageevaluationofgermanhealthinsurancedata
AT waltersbacherandrea prevalenceandtherapyratesforstutteringclutteringanddevelopmentaldisordersofspeechandlanguageevaluationofgermanhealthinsurancedata
AT schlotmannandreas prevalenceandtherapyratesforstutteringclutteringanddevelopmentaldisordersofspeechandlanguageevaluationofgermanhealthinsurancedata
AT schroderhelmut prevalenceandtherapyratesforstutteringclutteringanddevelopmentaldisordersofspeechandlanguageevaluationofgermanhealthinsurancedata
AT strzelczykadam prevalenceandtherapyratesforstutteringclutteringanddevelopmentaldisordersofspeechandlanguageevaluationofgermanhealthinsurancedata